Notably, the p53 status in IDH‐mutant gliomas plays a crucial role in tumor progression and response to temozolomide treatment [3, 15], requiring histological specimens obtained via surgical resection or stereotactic biopsy for accurate detection [3]. The gene discussed is TP53; the disease is central nervous system cancer.